Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
E

Everus Construction Group Inc
NYSE:ECG

Watchlist Manager
Everus Construction Group Inc
NYSE:ECG
Watchlist
Price: 152.37 USD -2.3% Market Closed
Market Cap: $7.8B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...

Wall St Price Targets

ECG Price Targets Summary
Everus Construction Group Inc

Wall Street analysts forecast ECG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ECG is 169.12 USD with a low forecast of 142.41 USD and a high forecast of 194.25 USD.

ECG Lowest Forecast
142.41 USD
-7% Downside
ECG Average Forecast
169.12 USD
11% Upside
ECG Highest Forecast
194.25 USD
27% Upside
Lowest Forecast
Price Target
142.41 USD
7% Downside
Average Forecast
Price Target
169.12 USD
11% Upside
Highest Forecast
Price Target
194.25 USD
27% Upside
Everus Construction Group Inc Competitors:
Price Targets
LFT
Lument Finance Trust Inc
148% Upside
H
HQF
High Quality Food SpA
164% Upside
LFT
Lument Finance Trust Inc
148% Upside
H
HQF
High Quality Food SpA
164% Upside

Revenue
Forecast

12% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

18% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.

What are analyst estimates?

Operating Income
Forecast

17% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
17% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is 14%.

What are analyst estimates?

Pre-Tax Income
Forecast

17% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
17% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 15%.

What are analyst estimates?

Net Income
Forecast

17% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
17% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 13%.

What are analyst estimates?

See Also

Summary
ECG intrinsic value, competitors valuation, and company profile.
DCF Valuation
ECG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ECG stock valuation using valuation multiples.
Wall St Estimates
ECG price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ECG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ECG's stock price target?
Price Target
169.12 USD

According to Wall Street analysts, the average 1-year price target for ECG is 169.12 USD with a low forecast of 142.41 USD and a high forecast of 194.25 USD.

What is the Revenue forecast for Everus Construction Group Inc?
Projected CAGR
12%

Over the last 3 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 12%.

What is the Gross Profit forecast for Everus Construction Group Inc?
Projected CAGR
14%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for Everus Construction Group Inc?
Projected CAGR
14%

Over the last 3 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 3 years is 14%.

What is the Pre-Tax Income forecast for Everus Construction Group Inc?
Projected CAGR
15%

Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Everus Construction Group Inc?
Projected CAGR
13%

Over the last 3 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join 343,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett